09966.HK_Providing professional financial news and data related to 09966.HK, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Jiangsu Alphamab Oncology-B(09966.HK): Phase II Clinical Trial of JSKN033 as First-line Therapy for Advanced Cervical Cancer Completes First Patient Dosing

Tags：

Jiangsu Alphamab Oncology-B 09966.HK

2026-05-13

ETF
E Fund (Hk) Ftse Ai Select Index Etf(03489.HK) Rises 1.17% Intraday at HK$13.84
ETF
Csop Nikkei 225 Daily (2x) Leveraged Product(07262.HK) Rises 1.89% Intraday, NAV Per Unit Stands at HK$185.367
ETF
CSOP STAR 50 Index ETF(03109.HK) Rises 3.94% Intraday with Turnover of HK$18.2496 Million
ETF
CSOP NVIDIA Daily (2x) Leveraged Product(07788.HK) Surges 7.85% Intraday at HK$154.60
Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (July 8, 2026)
Finance
China Feihe (06186.HK): Subscribes to RMB 300 Million Financial Products of SPD Bank
Finance
361 Degrees (01361.HK): Change of Independent Non-executive Director, Chan Yee Fong Appointed
ETF
Csop Ftse Hk-Korea Tech+ Index Etf(03431.HK) Rises 0.19% Intraday, Turnover Hits HK$68.9154 Million
ETF
E Fund (Hk) Solactive Asia Semiconductor Select Index Etf(03486.HK) Rises 0.35% Intraday with NAV Per Unit at HK$22.424
ETF
Premia FTSE TWSE Taiwan 50 ETF(03453.HK) Rises 0.74% Intraday with Average Traded Price of HK$169.690

Scan QR Code

Download App